GSK Plc Director/PDMR Shareholding
May 25 2022 - 9:41AM
UK Regulatory
TIDMGSK
GSK plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA�&#
65533;)
a) Name Dr H Barron
b) Position/status Chief Scientific Officer and President, R&D
c) Initial Initial notification
notification/
amendment
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name GSK plc
b) LEI 5493000HZTVUYLO1D793
3. Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been conducted
a) Description of American Depositary Shares ('ADSs')
the financial
instrument ISIN: US37733W1053
b) Nature of the Acquisition of notional ADSs within Dr Barron's
transaction GSK Executive Supplemental Savings Plan account.
c) Price(s) and Price(s) Volume(s)
volume(s)
$44.7500 1,151.020
d) Aggregated N/A (single transaction)
information
Aggregated volume
Price
e) Date of the 2022-05-23
transaction
f) Place of the New York Stock Exchange (XNYS)
transaction
END
(END) Dow Jones Newswires
May 25, 2022 10:41 ET (14:41 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024